Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Medicine and Dentistry
Ovarian Cancer
100%
Patient
70%
Neoplasm
65%
Vasculotropin
50%
Cells
42%
Combination Therapy
38%
Malignant Neoplasm
36%
Gynecological Oncology
34%
Phenotype
33%
Tumor-Related Gene
33%
Drive
33%
Cervical Cancer
33%
Collagen
33%
Cancer Cell
30%
Uterine Cancer
27%
In Vitro
26%
Cancer
26%
Metastatic Carcinoma
25%
Angiogenesis
22%
Woman
20%
Surgery
20%
Diseases
19%
Marker
19%
Tumor Progression
18%
Cell Death
18%
Stress
18%
Therapeutic Procedure
18%
Biopsy
17%
Platelet
17%
Cytoreductive Surgery
16%
Microenvironment
16%
Wound
16%
Papillomavirus Infection
16%
Neoadjuvant Chemotherapy
16%
Anoikis
16%
Laparotomy
16%
4 Iodo 2,5 Dimethoxyamphetamine
16%
Pelvis
16%
Therapy Resistance
16%
Drug Resistance
16%
Introspection
16%
Minimally Invasive Surgery
16%
Acetylsalicylic Acid
16%
Lesion
16%
Angiosarcoma
16%
Connective Tissue Growth Factor
16%
Mitogen-Activated Protein Kinase
16%
Cancer Associated Fibroblast
16%
Hyperthermia
16%
Pain
16%
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor
38%
Overall Survival
27%
Mouse
19%
Clinical Trial
16%
YAP1
16%
Drug Resistance
16%
Blood Level
16%
Cytokine
16%
Long Non-Coding RNA
16%
Collagen
16%
Fibroblast
16%
Phenotype
16%
Drive
16%
Transcriptome
16%
Transcription Factor
16%
INHBA
16%
Growth
13%
Survival
13%
Antiangiogenic Activity
13%
Bevacizumab
12%
Cancer Cell
12%
Interleukin-6
11%
Cortisol
11%
Sample
10%
Small Interfering RNA
10%
RNA Sequence
9%
Angiogenesis
8%
Antibody
7%
Electric Potential
7%
RNA
6%
Nested Gene
6%
Mouse Model
5%
Propranolol
5%
Protein Array
5%
STAT3
5%
Proinflammatory Cytokine
5%
PBX1
5%
Cell Oncogene
5%
Glucocorticoid
5%
Modulation
5%
GATA1
5%
GATA2
5%
YY1
5%
TRAIL
5%
ZEB1
5%
COX-2 Inhibitor
5%
Protein
5%
Association
5%
Immunology and Microbiology
Vasculotropin
38%
Macrophage
33%
Mouse
25%
Immunity
20%
Vasculotropin Antibody
19%
Blood Level
16%
Breast
16%
Transcriptome
16%
Colony Stimulating Factor 1 Receptor
16%
Transcription Factor
16%
Growth
12%
Sample
11%
Tumor Necrosis Factor
11%
Overall Survival
11%
Cortisol
11%
Experiment
11%
Antiangiogenic Activity
9%
Bevacizumab
8%
Angiogenesis
8%
Tumor Volume
8%
Mouse Model
7%
Blood Sampling
5%
Inflammation
5%
Tissues
5%
Proinflammatory Cytokine
5%
Interleukin 18
5%
Glucocorticoid
5%
Cell Oncogene
5%
Transcription Factor GATA 2
5%
TRAIL
5%
STAT3
5%
Staining
5%
Transcription Factor GATA 1
5%
Systemic Inflammation
5%
Prostaglandin
5%
Modulation
5%
